Akebia Therapeutics Total Liabilities 2011-2026 | AKBA

Annual Total Liabilities Akebia Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
344 M	270 M	272 M	351 M	455 M	397 M	376 M	361 M	245 M	232 M	11.9 M	6.92 M	3.91 M	4.92 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
455 M	3.91 M	238 M

Quarterly Total Liabilities Akebia Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
323 M	316 M	286 M	270 M	258 M	254 M	-	272 M	274 M	281 M	291 M	351 M	422 M	471 M	509 M	449 M	465 M	437 M	415 M	397 M	397 M	397 M	397 M	376 M	376 M	376 M	376 M	361 M	361 M	361 M	361 M	242 M	242 M	242 M	242 M	232 M	232 M	232 M	232 M	11.9 M	11.9 M	11.9 M	11.9 M	6.92 M	6.92 M	6.92 M	6.92 M	3.91 M	3.91 M	3.91 M	3.91 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
509 M	3.91 M	257 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	28.4 M	-	2.71 %	$ 14 M	USA
I-Mab IMAB	707 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	6.61 M	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
AbCellera Biologics ABCL	390 M	$ 3.66	1.25 %	$ 1.09 B	Canada
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	6.46 M	-	-18.52 %	$ 27.3 M	Britain
Black Diamond Therapeutics BDTX	39.4 M	$ 2.4	-3.04 %	$ 132 M	USA
ARCA biopharma ABIO	13.8 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	395 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	5.38 M	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	109 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
AIkido Pharma AIKI	7.27 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	126 M	-	-0.23 %	$ 916 M	USA
Alector ALEC	263 M	$ 2.12	-12.96 %	$ 218 M	USA
Allena Pharmaceuticals ALNA	15.9 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	7.8 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	5.24 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	107 M	-	-	$ 2.17 B	USA
Aeterna Zentaris AEZS	21.9 M	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	46.6 M	-	-	$ 10.1 M	USA
Aravive ARAV	51.5 M	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	14.7 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	28.4 M	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	13.9 M	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	38.9 M	-	17.91 %	$ 11.1 M	USA
Altimmune ALT	15.8 M	$ 4.22	-2.09 %	$ 300 M	USA
Arena Pharmaceuticals ARNA	110 M	-	-6.81 %	$ 3.04 B	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
Avenue Therapeutics ATXI	816 K	-	-52.27 %	$ 4.45 M	USA
Athersys ATHX	28.4 M	-	3.77 %	$ 22.4 M	USA
Axcella Health AXLA	14.8 M	-	-16.42 %	$ 249 M	USA
AstraZeneca PLC AZN	65.4 B	-	-	$ 96.9 B	Britain
AVEO Pharmaceuticals AVEO	59.5 M	-	-	$ 521 M	USA
Atreca BCEL	76.6 M	-	-11.76 %	$ 5.79 M	USA
Apellis Pharmaceuticals APLS	705 M	$ 20.76	-0.95 %	$ 2.62 B	USA
AVROBIO AVRO	6.35 M	-	1083.1 %	$ 745 M	USA
Agenus AGEN	387 M	$ 3.35	0.45 %	$ 1.2 M	USA
Ayala Pharmaceuticals AYLA	7.43 M	-	-	$ 7.46 M	Israel
Agios Pharmaceuticals AGIO	104 M	$ 28.99	-4.1 %	$ 1.68 B	USA
bluebird bio BLUE	425 M	-	-	$ 546 M	USA
Brickell Biotech BBI	6.5 M	-	-5.38 %	$ 6.06 M	USA